Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.50 (0.17%)
Bid:
302.00
Ask:
302.50
Spread: 0.50 (0.166%)
Market Cap: £178.29m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Form 8.3 - Treatt plc

Today 15:25

RNS Number : 4476H
Glazer Capital, LLC
08 June 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Glazer Capital, LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Treatt plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

June 5, 2026

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

2p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3

0.00%

 

 

(2) Derivatives (other than options):

1,935,780

3.25%

 

 

(3) Options and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

1,935,783

3.25%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

2p ordinary

Total return equity swaps

Increasing a long position

192,824

3.02 GBP

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

June 8, 2026

Contact name:

Anny Kim

Telephone number:

212-804-9971

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFPMJTMTTMBMF
Date   Source Headline
29th Apr 20267:00 amRNSRecommended cash acquisition of Treatt plc
7th Apr 20267:00 amRNSDirectorate and Board Committee Changes
26th Mar 20263:52 pmRNSResult of AGM
26th Mar 20267:00 amRNSAGM Trading Update
4th Mar 20264:00 pmRNSHolding(s) in Company
19th Feb 20262:54 pmRNSVoting Rights and Capital
12th Feb 20267:00 amRNSUpdate on CFO Recruitment and Board Committees
30th Jan 20264:13 pmRNSAnnual Report and Notice of Annual General Meeting
26th Jan 20264:02 pmRNSHolding(s) in Company
20th Jan 20267:01 amRNSRelationship Agreement and Board Appointment
20th Jan 20267:00 amRNSFull Year Results
12th Jan 20264:25 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSBoard and Management Appointments & Results Notice
3rd Dec 20257:00 amRNSDirectorate change
1st Dec 202510:24 amRNSBlock Listing Six Monthly Return
1st Dec 202510:21 amRNSBlock Listing Six Monthly Return
25th Nov 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSDirectorate change
4th Nov 20251:15 pmRNSForm 8.3 - Treatt Plc
4th Nov 20251:09 pmRNSForm 8.3 TREATT PLC
4th Nov 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
4th Nov 20259:18 amGNWForm 8.5 (EPT/RI)-Treatt plc
3rd Nov 20253:41 pmRNSResults of Court Meeting and General Meeting
3rd Nov 20253:20 pmRNSForm 8.3 - Treatt Plc
3rd Nov 20253:17 pmRNSForm 8.3 - TREATT PLC
3rd Nov 20252:36 pmRNSForm 8.3 TREATT PLC
3rd Nov 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
3rd Nov 202511:11 amRNSForm 8.3 Treatt Plc
3rd Nov 202510:05 amGNWForm 8.5 (EPT/RI)-Treatt plc
31st Oct 20253:15 pmRNSForm 8.3 - Treatt Plc
31st Oct 20253:10 pmRNSForm 8.3 - TREATT PLC
31st Oct 202512:52 pmRNSForm 8.3 TREATT PLC
31st Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
31st Oct 202511:22 amRNSForm 8.3 - Treatt Plc
31st Oct 20259:15 amRNSHolding(s) in Company
31st Oct 20258:52 amRNSForm 8.3 - Treatt plc
30th Oct 20251:16 pmRNSForm 8.3 TREATT PLC
30th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
29th Oct 202512:40 pmRNSForm 8.3 TREATT PLC
29th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
28th Oct 20253:20 pmRNSForm 8.3 - Treatt Plc
28th Oct 202512:42 pmRNSForm 8.3 - Treatt Plc
28th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
28th Oct 202510:28 amRNSForm 8.3 TREATT PLC
27th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
27th Oct 202511:08 amRNSForm 8.3 - Treatt Plc
27th Oct 202511:06 amRNSForm 8.3 TREATT PLC
27th Oct 20257:00 amRNSStatement re Update on Irrevocable Undertakings
24th Oct 202512:25 pmRNSForm 8.3 - TREATT PLC
24th Oct 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.